03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Saizen 8mg* : | |
Type | Medicine Non Marketed |
Originator | Biotech (Saizen 8mg) |
Agent | Food & Drug Corporation |
Distributor | Food & Drug Corporation |
Laboratory | Merck |
Responsible Party | Merck Serono SpA |
Origin | Italy |
Manufacturer | Merck Serono SPA |
Origin | Italy |
ATC | H01AC01 |
Saizen 8mg* :
Saizen 8mg* :
Saizen 8mg* :
Saizen 8mg* :
Saizen 8mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Saizen 8mg* :
Saizen 8mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acne | Common |
Acrochordon | Common |
Adrenal insufficiency | Common |
Antibody test positive | Common |
Arthralgia (Pain joint) (Joint ache) | Common |
Arthritis | Common |
Asthenia | Common |
Back pain | Common |
Benign intracranial hypertension | Rare |
Blood cholesterol increased | Common |
Blood creatinine increased | Common |
Blood glucose increased | Common |
Blood insulin increased | Common |
Blood phosphorus increased | Common |
Blood pressure increased | Common |
Blood sodium decreased | Common |
Blood thyroid stimulating hormone increased | Common |
Blood triglycerides increased | Common |
Blood uric acid increased | Common |
Bone pain | Common |
Carpal tunnel syndrome | Common |
Chest pain | Common |
Cholecystitis | Common |
Conjunctivitis | Common |
Craniopharyngioma | Common |
Dermatitis allergic | Common |
Discomfort | Common |
Dizziness | Common |
Epistaxis (Nasal bleeding) | Common |
Face oedema | Common |
Fatigue | Common |
Generalized oedema | Very Common |
Glycosylated haemoglobin increased | Common |
Gynecomastia (Gynaecomastia) | Uncommon |
Haematuria (Hematuria) | Common |
Haemoglobin decreased | Common |
HDL cholesterol decreased | Common |
HDL increased | Common |
Headache | Very Common |
Heart rate abnormal | Common |
Heart rate increased | Common |
Herpes simplex | Common |
Hyperbilirubinaemia | Common |
Hyperglycaemia | Very Common |
Hyperhidrosis | Common |
Hyperlipidaemia | Common |
Hypertension | Common |
Hypoesthesia | Common |
Hypothyroidism | Common |
Impaired fasting glucose | Common |
Injection site pain | Common |
Insomnia | Common |
Insulin resistance | Not known |
Insulin-like growth factor increased | Common |
Joint swelling | Common |
LDL Increased | Common |
Leukocyte count decreased (White blood cell count decreased) | Common |
Liver function test abnormal | Common |
Local swelling | Common |
Localised oedema | Very Common |
Malaise | Common |
Muscle weakness | Common |
Musculoskeletal pain | Common |
Musculoskeletal stiffness | Common |
Myalgia | Common |
Nausea | Common |
Neoplasm progression | Common |
Nipple pain | Common |
Oedema | Common |
Oedema peripheral | Very Common |
Pain | Common |
Pain in extremity (Pain in limb) | Common |
Paraesthesia (paresthesia) | Common |
Skin rash | Common |
Somnolence | Common |
Swelling face | Common |
Tachycardia | Common |
Tendinitis (Tendonitis) | Common |
Thirst | Common |
Thyroxine free decreased | Common |
Tri-iodothyronine free decreased | Common |
Urticaria | Common |
Vertigo | Common |
Visual acuity reduced | Common |
Weight increased (weight gain) | Common |
White blood cell count increased | Common |
Saizen 8mg* :
Different Units By MoH Code
Saizen 8mg* MoH 6701 :
Form | Powder and solvent for solution for injection |
Packaging | Vial + Cartridge |
Package Size | Box of 1+1 |
Strength | 8mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 167839/11 |
Submission date | 01/01/2011 |
Registration Year | 2012 |
Archived Date | 2019 |
Price Comparison
● Country: | Italy | |
● Package Size: | 1 | |
● Public Price: | 345.33 EUR | ( 33,454,189.08 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 43,1662 EUR | ( 4,165,668.00 LBP ) |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 1 | |
● Public Price: | 264.64 EUR | ( 25,637,264.64 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 33,08 EUR | ( 3,196,908.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 30/01/2018 | |
● Type: | Medicine Non Marketed |
● Country: | France | |
● Package Size: | 1 | |
● Public Price: | 249.74 EUR | ( 24,193,812.24 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 31,2175 EUR | ( 3,003,156.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Qatar | |
● Package Size: | 1 | |
● Public Price: | 974 QAR | ( 23,919,492.00 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 121,75 QAR | ( 2,971,518.00 LBP ) |
● Pharmacy Price: | 799.681935676 QAR | ( 19638588.976331 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 1 | |
● Public Price: | 242.14 EUR | ( 23,457,554.64 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 30,2675 EUR | ( 2,906,280.00 LBP ) |
● Pricing Date: | 26/02/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Oman | |
● Package Size: | 1 | |
● Public Price: | 102.5 OMR | ( 23,650,235.00 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 12,8125 OMR | ( 2,768,808.00 LBP ) |
● Pricing Date: | 15/12/2018 | |
● Type: | Medicine Non Marketed |
● Country: | UAE | |
● Package Size: | 1 Vial (Powder) + 1 Solvent Cartridge + 1 click.easy device | |
● Public Price: | 911.5 AED | ( 22,022,751.50 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 113,9375 AED | ( 2,730,193.00 LBP ) |
● Pharmacy Price: | 776.57 AED | ( 18762707.77 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 1 | |
● Public Price: | 911.5 AED | ( 22,022,751.50 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 113,9375 AED | ( 2,730,193.00 LBP ) |
● Pharmacy Price: | 776.57 AED | ( 18762707.77 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1 | |
● Public Price: | 185.44 GBP | ( 21,075,070.56 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 23,18 GBP | ( 2,613,927.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 8 | |
● Public Price: | 833.15 SAR | ( 19,695,666.00 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 104,1438 SAR | ( 2,458,560.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 1 + 1 | |
● Public Price: | 86.53 BHD | ( 20,571,123.02 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 10,8162 BHD | ( 2,377,340.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 23/09/2018 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 1 vial + 1 cartucho de disolvente | |
● Public Price: | 193.35 EUR | ( 18,730,974.60 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 24,1688 EUR | ( 2,325,024.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Greece | |
● Package Size: | 1+1 | |
● Public Price: | 189.48 EUR | ( 18,356,064.48 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 23,685 EUR | ( 2,228,148.00 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/03/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Turkey | |
● Package Size: | 1 | |
● Public Price: | 616.67 TRY | ( 1,652,675.60 LBP ) |
● Pack size unit used: | 8 | |
● Cost/Unit: | 77,0838 TRY | ( 206,360.00 LBP ) |
● Pricing Date: | 31/12/2019 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File